The future of biometrics in cancer care is promising, with ongoing advancements in technology and data analysis methods. The integration of artificial intelligence and machine learning will likely revolutionize the way biometric data is interpreted, leading to more precise and personalized treatment plans. Additionally, the development of novel biomarkers and less invasive testing methods will further enhance the early detection and monitoring of cancer. Collaborative efforts between researchers, clinicians, and policymakers will be essential to overcome existing challenges and fully realize the potential of biometrics in cancer care.
